AfNHi is an African led network of HIV prevention research advocate.
Based in Africa borne out of a joint vision by African Advocates. AfNHi is seeking to fast-track the biomedical HIV prevention research agenda on the continent through local ownership, using indigenous strategies to enhance Africa’s contribution to the Global goals.
10
%
of people living with HIV received ART in 2022
10
.5m
New HIV infections in 2022
10
.7
Number of people living with HIV in 2022
10
.7m
People were accessing antiretroviral therapy in 2021.
The network began as an extended exchange around the need to champion African led advocacy in biomedical HIV prevention research among colleagues including WACI Health, New HIV Vaccine and Microbicides Advocacy Society (NHVMAS) and individual advocates.